Back to All

Leveraging DXRX Signal to drive commercial success

4 April, 2022

Featured

The pace of advancement in Precision Medicine has been tremendous and has resulted in far greater outcomes for patients than some thought possible 20 years ago. However, with the increasing number of biomarkers and the technological advancement in testing, this has created challenges for physicians to keep pace, with a recent Journal of Clinical Oncology (JCO) publication stating that physicians encounter issues when interpreting genomic test results, leading to patients receiving broad spectrum therapies which are less efficacious and with increased side effects.

The ability to engage physicians with appropriate education at the right time is critical for the life science industry in both routine clinical practice and clinical trial setting, to support the adoption of Precision Medicine, which has demonstrated superior outcomes and cost effectiveness.  DXRX Signal delivers an actionable alert of a testing behavior that enables industry to engage physicians before treatment decisions have been made. By receiving DXRX Signal alerts and engaging physicians within this timeframe, biopharmaceutical companies can maximize the effectiveness of brand sales and marketing activities, resulting in commercial success,  with patients getting the treatment they deserve.  DXRX Signalpowered by 493 labs and our leading experts in Precision Medicine and Machine Learning, can specifically design alerts for a variety of clinical situations, for example, 2L setting based on multiple tracked testing events or risk stratification status based on multiple biomarker results. 

Utilizing lab data is critical for providing the earliest identification of physicians with potentially eligible patients and therefore has the greatest impact on the adoption of Precision Medicine. DXRX Signal Alerts have been successfully employed in several settings including oncology, rare diseases, auto-immune, cardiovascular, and infectious diseases 

 Ready to add Precision to your data strategy?  Get in touch today to schedule a demo. Click here: Request a Demo - Diaceutics 

 

 

 

 

 

 

 

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny